Cargando…

A pilot study of risk-stratified cervical cancer screening

Background: Cervical screening programs target entire populations, although it is well established that cervical cancer risks can vary >100-fold based, in particular, on the woman’s screening history. Since cervical screening switched to Human Papillomavirus (HPV) testing as the primary screening...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiangrong, Elfström, K. Miriam, Borgfeldt, Christer, Dillner, Joakim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445943/
https://www.ncbi.nlm.nih.gov/pubmed/37645164
http://dx.doi.org/10.12688/openreseurope.13398.2
_version_ 1785094294181249024
author Wang, Jiangrong
Elfström, K. Miriam
Borgfeldt, Christer
Dillner, Joakim
author_facet Wang, Jiangrong
Elfström, K. Miriam
Borgfeldt, Christer
Dillner, Joakim
author_sort Wang, Jiangrong
collection PubMed
description Background: Cervical screening programs target entire populations, although it is well established that cervical cancer risks can vary >100-fold based, in particular, on the woman’s screening history. Since cervical screening switched to Human Papillomavirus (HPV) testing as the primary screening method, the risk differences are even larger as different HPV types may vary in associated cancer risk by 100 times. Furthermore, HPV infections with the most oncogenic types are declining dramatically because of HPV vaccination programs. Tailoring screening intensity based on the known cancer risk of the individual (risk-stratified screening) therefore has great potential to increase both the sensitivity and specificity. Within Horizon 2020 a major project for Risk-stratified Screening for Cervical Cancer (RISCC) has therefore been launched. We performed a pilot study of risk-stratified screening to evaluate feasibility and acceptability of offering vaginal HPV self-sampling tests to women with a higher risk of cervical cancer. Methods: We identified resident women who had had either i) atypical glandular cells in screening tests during the past six years (risk >150/100,000 woman-years) or ii) abnormal screening findings above the age of 50, but without sufficient follow-up (risk >65/100,000). The women were invited, either by short message service (SMS) or physical letters, to order an HPV self-sampling kit via the study web-platform. The returned self-collected samples were tested for HPV. If positive, women were invited for clinical follow-up. Results: Among 920 targeted women, 191 (21%) placed an order and 163 (18%) returned a self-collected sample. Among all tested samples, 19 (12%) were positive for hrHPV and 18 of these women attended clinical follow-up. Conclusions: SMS invitations to high-risk women complemented with physical letters are feasible and result in substantial requests for kits and submission of samples. Future work will focus on improving the efficiency of the procedure and further increasing attendance.
format Online
Article
Text
id pubmed-10445943
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-104459432023-08-29 A pilot study of risk-stratified cervical cancer screening Wang, Jiangrong Elfström, K. Miriam Borgfeldt, Christer Dillner, Joakim Open Res Eur Research Article Background: Cervical screening programs target entire populations, although it is well established that cervical cancer risks can vary >100-fold based, in particular, on the woman’s screening history. Since cervical screening switched to Human Papillomavirus (HPV) testing as the primary screening method, the risk differences are even larger as different HPV types may vary in associated cancer risk by 100 times. Furthermore, HPV infections with the most oncogenic types are declining dramatically because of HPV vaccination programs. Tailoring screening intensity based on the known cancer risk of the individual (risk-stratified screening) therefore has great potential to increase both the sensitivity and specificity. Within Horizon 2020 a major project for Risk-stratified Screening for Cervical Cancer (RISCC) has therefore been launched. We performed a pilot study of risk-stratified screening to evaluate feasibility and acceptability of offering vaginal HPV self-sampling tests to women with a higher risk of cervical cancer. Methods: We identified resident women who had had either i) atypical glandular cells in screening tests during the past six years (risk >150/100,000 woman-years) or ii) abnormal screening findings above the age of 50, but without sufficient follow-up (risk >65/100,000). The women were invited, either by short message service (SMS) or physical letters, to order an HPV self-sampling kit via the study web-platform. The returned self-collected samples were tested for HPV. If positive, women were invited for clinical follow-up. Results: Among 920 targeted women, 191 (21%) placed an order and 163 (18%) returned a self-collected sample. Among all tested samples, 19 (12%) were positive for hrHPV and 18 of these women attended clinical follow-up. Conclusions: SMS invitations to high-risk women complemented with physical letters are feasible and result in substantial requests for kits and submission of samples. Future work will focus on improving the efficiency of the procedure and further increasing attendance. F1000 Research Limited 2022-09-01 /pmc/articles/PMC10445943/ /pubmed/37645164 http://dx.doi.org/10.12688/openreseurope.13398.2 Text en Copyright: © 2022 Wang J et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wang, Jiangrong
Elfström, K. Miriam
Borgfeldt, Christer
Dillner, Joakim
A pilot study of risk-stratified cervical cancer screening
title A pilot study of risk-stratified cervical cancer screening
title_full A pilot study of risk-stratified cervical cancer screening
title_fullStr A pilot study of risk-stratified cervical cancer screening
title_full_unstemmed A pilot study of risk-stratified cervical cancer screening
title_short A pilot study of risk-stratified cervical cancer screening
title_sort pilot study of risk-stratified cervical cancer screening
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445943/
https://www.ncbi.nlm.nih.gov/pubmed/37645164
http://dx.doi.org/10.12688/openreseurope.13398.2
work_keys_str_mv AT wangjiangrong apilotstudyofriskstratifiedcervicalcancerscreening
AT elfstromkmiriam apilotstudyofriskstratifiedcervicalcancerscreening
AT borgfeldtchrister apilotstudyofriskstratifiedcervicalcancerscreening
AT dillnerjoakim apilotstudyofriskstratifiedcervicalcancerscreening
AT wangjiangrong pilotstudyofriskstratifiedcervicalcancerscreening
AT elfstromkmiriam pilotstudyofriskstratifiedcervicalcancerscreening
AT borgfeldtchrister pilotstudyofriskstratifiedcervicalcancerscreening
AT dillnerjoakim pilotstudyofriskstratifiedcervicalcancerscreening